Developer of a digital histopathology screening platform intended to detect cancer in a single tissue biopsy. The company's platform provides a digital multi-colored image of the tissue biopsy which is analysed by a software that assists the clinical decision making process of diagnosis, enabling physicians to take targeted decisions regarding treatments and have high success rate of patient outcome.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Grant | 27-Nov-2018 | $1.26M | 00000 | Completed | Generating Revenue | |
6. Grant | 23-Oct-2018 | 000.00 | 00000 | Completed | Generating Revenue | |
5. Early Stage VC | 21-Dec-2017 | 00000 | 00000 | 00.000 | Completed | Generating Revenue |
4. Early Stage VC | 20-Dec-2016 | 00000 | 00000 | 00.000 | Completed | Startup |
3. Seed Round | 01-Apr-2016 | 00000 | 00000 | 00.000 | Completed | Startup |
2. Accelerator/Incubator | $158K | Completed | Startup | |||
1. Seed Round | 31-Jul-2015 | $158K | $158K | 00000 | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
A Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
A Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
A Ordinary | 2,333 | $0.013389 | $100.42 | $100.42 | 1x | $100.42 | 13.68% | |
Ordinary | 1,990 | $0.013389 | $68.31 | $68.31 | 1x | $68.31 | 11.67% |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Mark McCairn Ph.D | Co-Founder, Chief Executive Officer & Board Member | ||
Michael Turner Ph.D | Co-Founder, Board Member, Scientific & Technical Advisor |
Name | Representing | Role | Since |
---|---|---|---|
Mark Frost | Chromition | Chairman | 000 0000 |
Mark McCairn Ph.D | Chromition | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Michael Turner Ph.D | Chromition | Co-Founder, Board Member, Scientific & Technical Advisor | 000 0000 |
Perry van Rijsingen | Self | Board Member & Strategic Advisor | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
SBRI Healthcare | Government | 000 0000 | 000000 0 | ||
Horizon 2020 | Government | 000 0000 | 000000 0 | ||
Mercia Asset Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
MTI Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
NETPark Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |